Results 51 to 60 of about 66,971 (207)

Rapid evolution of fluoroquinolone-resistant Escherichia coli in Nigeria is temporally associated with fluoroquinolone use

open access: yesBMC Infectious Diseases, 2011
Background Antibiotic resistance has necessitated fluoroquinolone use but little is known about the selective forces and resistance trajectory in malaria-endemic settings, where selection from the antimalarial chloroquine for fluoroquinolone-resistant ...
Lamikanra Adebayo   +6 more
doaj   +1 more source

Efficiency of danofloxacin in treatment of pig colibacteriosis

open access: yesБіологія тварин, 2020
The article presents the study results of the third-generation fluoroquinolone antibiotic danofloxacin efficacy and safeness in the treatment of pig colibacillosis.
T. I. Stetsko
doaj   +1 more source

Fluoroquinolones Inhibit HCV by Targeting Its Helicase

open access: yes, 2011
Background HCV has infected >170 million individuals worldwide. Effective therapy against HCV is still lacking and there is a need to develop potent drugs against the virus.
Irfan A Khan   +4 more
core   +1 more source

Determination of 20 fluoroquinolones in milk based on magnetic molecularly imprinted microsphere and aggregation induced emission luminongen

open access: yesFood Chemistry: X
The residues of fluoroquinolones in foods of animal origin posed many threats to the consumer's health. The aim of this study was to developed a magnetic molecularly imprinted microsphere and aggregation induced emission luminogen based semi-homogeneous ...
Su Han Wang, Jian Ping Wang, Cheng Feng
doaj   +1 more source

Fluoroquinolone Antimicrobial Agents [PDF]

open access: yesNew England Journal of Medicine, 1989
The fluoroquinolones, a new class of potent orally absorbed antimicrobial agents, are reviewed, considering structure, mechanisms of action and resistance, spectrum, variables affecting activity in vitro, pharmacokinetic properties, clinical efficacy, emergence of resistance, and tolerability. The primary bacterial target is the enzyme deoxyribonucleic
D C, Hooper, J S, Wolfson
openaire   +3 more sources

Fluoroquinolones i problemes tendinosos [PDF]

open access: yes, 2015
Fluoroquinolones; Problemes tendinosos; Tractament farmacòlogicFluoroquinolonas; Problemas tendinosos; Tratamiento farmacológicoFluoroquinolones; Tendon problems; Pharmacological treatmentEs vol donar a conèixer la proporció de pacients tractats amb ...
Servei Català de la Salut. Àrea del Medicament
core  

In-Vitro Adsorption of Fluoroquinolones on Some Pharmaceutical Adsorbents

open access: yes, 2007
Purpose: Drug overdose and poisoning are common clinical problems and could occur with the fluoroquinolones – a new series of synthetic antimicrobial agents. It therefore becomes important to study the adsorption of the fluoroquinolones on pharmaceutical
Afolabi, A B, Eboka, C J
core   +1 more source

Fluoroquinolones cardiotoxicity [PDF]

open access: yes, 2020
The article discusses literature data on the effect of fluoroquinolones on the conduction system of the heart, and mechanisms for the development of their cardiotoxic effects.В статье рассмотрены данные литературы о влиянии фторхинолонов на проводящую ...
Izmozherova, N. V.   +7 more
core  

Les fluoroquinolones : Aspects pharmacologiques et toxicologiques

open access: yes, 1992
Fluoroquinolones : pharmacologic and toxicologic aspects Fluoroquinolones, fluorinated piperazinyl-substituted congeners of nalidixic acid, are new 4-quinolone antibacterial agents with an excellent activity.
Arturo Anadón, Anadón, Arturo
core   +1 more source

To compare the in vitro activity of 3 popular fluoroquinolones against common respiratory and middle ear pathogens

open access: yesBengal Journal of Otolaryngology and Head Neck Surgery, 2013
Antibiotic resistance among respiratory tract pathogens is increasing worldwide. Beta-lactam-resistant as well as macrolide and fluoroquinolone-resistant strains of the commonest pathogens  are being isolated with increasing frequency in manycountries .
Soma Sarkar   +3 more
doaj  

Home - About - Disclaimer - Privacy